129 related articles for article (PubMed ID: 38832694)
1. Cost-Effective Whole Transcriptome Sequencing Landscape and Diagnostic Potential Biomarkers in Active Tuberculosis.
Sun Z; He B; Yang Z; Huang Y; Duan Z; Yu C; Dan Z; Paek C; Chen P; Zhou J; Lei J; Wang F; Liu B; Yin L
ACS Infect Dis; 2024 Jun; 10(6):2318-2332. PubMed ID: 38832694
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis.
Lee SW; Wu LS; Huang GM; Huang KY; Lee TY; Weng JT
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):3. PubMed ID: 26818387
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection.
Yang BF; Zhai F; Yu S; An HJ; Cao ZH; Liu YH; Wang R; Cheng XX
Curr Med Sci; 2022 Dec; 42(6):1201-1212. PubMed ID: 36462134
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis.
Wang S; He L; Wu J; Zhou Z; Gao Y; Chen J; Shao L; Zhang Y; Zhang W
Front Immunol; 2019; 10():2948. PubMed ID: 31921195
[No Abstract] [Full Text] [Related]
5. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
[TBL] [Abstract][Full Text] [Related]
6. Comparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler.
Johnson WE; Odom A; Cintron C; Muthaiah M; Knudsen S; Joseph N; Babu S; Lakshminarayanan S; Jenkins DF; Zhao Y; Nankya E; Horsburgh CR; Roy G; Ellner J; Sarkar S; Salgame P; Hochberg NS
BMC Infect Dis; 2021 Jan; 21(1):106. PubMed ID: 33482742
[TBL] [Abstract][Full Text] [Related]
7. Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells.
Lu C; Wu J; Wang H; Wang S; Diao N; Wang F; Gao Y; Chen J; Shao L; Weng X; Zhang Y; Zhang W
PLoS One; 2011; 6(8):e24290. PubMed ID: 21904626
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach.
Natarajan S; Ranganathan M; Hanna LE; Tripathy S
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456421
[TBL] [Abstract][Full Text] [Related]
9. Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier Evaluation.
Walter ND; Miller MA; Vasquez J; Weiner M; Chapman A; Engle M; Higgins M; Quinones AM; Rosselli V; Canono E; Yoon C; Cattamanchi A; Davis JL; Phang T; Stearman RS; Datta G; Garcia BJ; Daley CL; Strong M; Kechris K; Fingerlin TE; Reves R; Geraci MW
J Clin Microbiol; 2016 Feb; 54(2):274-82. PubMed ID: 26582831
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-related gene biomarkers for latent and active tuberculosis.
Li Y; Deng Y; He J
Bioengineered; 2021 Dec; 12(2):10799-10811. PubMed ID: 34751089
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
[TBL] [Abstract][Full Text] [Related]
12. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection.
Dawany N; Showe LC; Kossenkov AV; Chang C; Ive P; Conradie F; Stevens W; Sanne I; Azzoni L; Montaner LJ
PLoS One; 2014; 9(2):e89925. PubMed ID: 24587128
[TBL] [Abstract][Full Text] [Related]
14. A Two-Gene Signature for Tuberculosis Diagnosis in Persons With Advanced HIV.
Kulkarni V; Queiroz ATL; Sangle S; Kagal A; Salvi S; Gupta A; Ellner J; Kadam D; Rolla VC; Andrade BB; Salgame P; Mave V
Front Immunol; 2021; 12():631165. PubMed ID: 33692804
[No Abstract] [Full Text] [Related]
15. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
16. Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from south India.
Leong S; Zhao Y; Joseph NM; Hochberg NS; Sarkar S; Pleskunas J; Hom D; Lakshminarayanan S; Horsburgh CR; Roy G; Ellner JJ; Johnson WE; Salgame P
Tuberculosis (Edinb); 2018 Mar; 109():41-51. PubMed ID: 29559120
[TBL] [Abstract][Full Text] [Related]
17. Screening of potential biomarkers for distinguishing between latent and active tuberculosis in children using bioinformatics analysis.
Shao M; Wu F; Zhang J; Dong J; Zhang H; Liu X; Liang S; Wu J; Zhang L; Zhang C; Zhang W
Medicine (Baltimore); 2021 Feb; 100(5):e23207. PubMed ID: 33592820
[TBL] [Abstract][Full Text] [Related]
18. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
[TBL] [Abstract][Full Text] [Related]
19. CD38+CD27-TNF-α + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis.
Acharya MP; Pradeep SP; Murthy VS; Chikkannaiah P; Kambar V; Narayanashetty S; Burugina Nagaraja S; Gangadhar N; Yoganand R; Satchidanandam V
Clin Infect Dis; 2021 Sep; 73(5):793-801. PubMed ID: 34492697
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Parsimonious Tuberculosis Gene Signature Using the digital NanoString nCounter Platform.
Kaipilyawar V; Zhao Y; Wang X; Joseph NM; Knudsen S; Prakash Babu S; Muthaiah M; Hochberg NS; Sarkar S; Horsburgh CR; Ellner JJ; Johnson WE; Salgame P
Clin Infect Dis; 2022 Sep; 75(6):1022-1030. PubMed ID: 35015839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
